Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7A | Q13946 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | PDE7B | Q9NP56 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23372025 | 0.88 | PDK2 (0.32) | KMT2APDK2 | |
| SCHEMBL20845203 | 0.85 | LMNA (0.35) | PDE7ALMNASMN1; SMN2PDK2PDE7B | |
| SCHEMBL20198312 | 0.81 | MAOA (0.44) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL9905646 | 0.78 | MAOA (0.50) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL25052760 | 0.73 | KDM4E (0.41) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL15498442 | 0.72 | MAOA (0.55) | MAPTSMN1; SMN2MAOAMAOB | |
| SCHEMBL19773709 | 0.71 | KDM4E (0.40) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL19148000 | 0.71 | ALDH1A1 (0.47) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL24730200 | 0.70 | KDM4E (0.45) | LMNAKDM4EMEN1MAPTOPRK1 | |
| SCHEMBL996751 | 0.70 | PDK2 (0.58) | LMNAKDM4EMEN1MAPTOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147442-A1 | ORGANIC COMPOUND, ELECTROLUMINESCENT MATERIAL, AND APPLICATION THEREOF | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147442-A1 | ORGANIC COMPOUND, ELECTROLUMINESCENT MATERIAL, AND APPLICATION THEREOF | ILK, OSTC, LEF1 | PDE7A 4304/4885LMNA 603/4885KDM4E 3975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.